News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boehringer Ingelheim GmbH's Dabigatran: The Case of the Missing 110-mg Dose, Brigham and Women's Hospital Study



10/22/2010 6:29:34 AM

MedPageToday -- The mystery surrounding the doses of dabigatran (Pradaxa) approved this week by the FDA has not yet been fully solved, but the FDA has provided a partial answer.

Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES